Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 10/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 10/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 4/20 | 0.38 |
| ▸ | CA2 | P00918 | 4/20 | 0.38 |
| ▸ | CA4 | P22748 | 4/20 | 0.38 |
| ▸ | NPC1 | O15118 | 3/20 | 0.34 |
| ▸ | RAB9A | P51151 | 3/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | CA6 | P23280 | 3/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23817259 | 0.74 | CA1 (0.32) | KMT2ACA1CA2CA4 | |
| SCHEMBL17065221 | 0.74 | CA1 (0.32) | KMT2ACA1CA2CA4 | |
| SCHEMBL28088919 | 0.74 | PTGS1 (0.40) | PTGS1PTGS2KMT2AOPRK1HTT | |
| SCHEMBL2691668 | 0.73 | PTGS1 (0.44) | PTGS1PTGS2KMT2AOPRK1HTT | |
| SCHEMBL10962415 | 0.71 | CA1 (0.31) | CA1CA2CA4 | |
| SCHEMBL27214521 | 0.71 | NPC1 (0.38) | PTGS1PTGS2KMT2AOPRK1HTT | |
| SCHEMBL27231331 | 0.71 | NPC1 (0.38) | PTGS1PTGS2KMT2AOPRK1HTT | |
| SCHEMBL1427225 | 0.71 | NPC1 (0.38) | PTGS1PTGS2KMT2AOPRK1HTT | |
| SCHEMBL901072 | 0.71 | NPC1 (0.38) | PTGS1PTGS2KMT2AOPRK1HTT | |
| SCHEMBL27214519 | 0.71 | NPC1 (0.38) | PTGS1PTGS2KMT2AOPRK1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3778843-A1 | MUSK-LIKE COMPOSITION | Kao Corporation (JP) | 2021-02-17 | — | — | EP | disclosed |
| US-20140163099-A1 | ANTIMICROBIAL COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2014-06-12 | — | — | US | disclosed |
| EP-2725900-A1 | ANTIMICROBIAL COMPOSITION | Takasago International Corporation (JP) | 2014-05-07 | — | — | EP | disclosed |
| WO-2013002421-A1 | ANTIMICROBIAL COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-01-03 | — | — | WO | disclosed |
| US-20130005807-A1 | ANTIMICROBIAL COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-01-03 | — | — | US | disclosed |
| US-7964637-B2 | Process for producing optically active theaspirane | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-06-21 | — | — | US | disclosed |
| US-20090270516-A1 | Process for Producing Optically Active Theaspirane | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-10-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090270516-A1 | Process for Producing Optically Active Theaspirane | DHPS, ALDH7A1, FASN | PTGS1 1421/4885PTGS2 1240/4885KMT2A 1705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.